Journal of Clinical and Experimental Hematopathology : JCEH This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Treatment patterns in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma post covalent Bruton tyrosine kinase inhibitor treatment: a Japanese claims database study
In conclusion, Japanese patients with CLL/SLL received various treatments for short duration after first-cBTKi discontinuation.PMID:38148012 | DOI:10.3960/jslrt.23032 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Dai Maruyama Chaochen Wang Yoshinori Tanizawa Zhihong Cai Yujing Huang Masaomi Tajimi Shigeru Kusumoto Source Type: research
Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma
In this study, we aimed to investigate the prevalence of EBV among HL cases in Ethiopia and to assess the tissue cellular composition of EBV-related and EBV-unrelated cases. We constructed a tissue microarray (TMA) of 126 consecutive cases of classical HL (CHL) and nodular lymphocyte predominant HL (NLPHL) from a tertiary cancer centre, Tikur Anbessa Hospital, Addis Ababa, Ethiopia, and evaluated a panel of immunohistochemical markers. The quantification of immune cells was performed using HALO 2.3, a platform for image analysis from Indica Lab Inc. A total of 77/126 (61.1%) of HL cases expressed LMP1/EBER. Infiltration of...
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Makka Adam Yonas Bekuretsion Amha Gebremedhin Anna Kwiecinska Rawleigh Howe Beyene Petros Mats Jerkeman Source Type: research
Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease
This report suggests that appropriate sutimlimab administration can suppress SARS-CoV-2 mRNA vaccination-induced CAD exacerbation, and that it could be a preventive strategy to minimize hemolytic attacks in susceptible populations.PMID:38148014 | DOI:10.3960/jslrt.23040 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Hiroki Kobayashi Tomoki Ouchi Wataru Kitamura Shoji Asakura Tomofumi Yano Hiromasa Takeda Yoshiyuki Tokuda Tadashi Yoshino Yoshinobu Maeda Source Type: research
Methotrexate-induced subacute myelopathy: a serious but treatable complication
J Clin Exp Hematop. 2023;63(4):251-256. doi: 10.3960/jslrt.23041.ABSTRACTSubacute myelopathy is a rare but serious complication of methotrexate (MTX) that may cause paraplegia. Although its underlying mechanisms have not been fully elucidated, homocysteine is thought to play a role in the pathogenesis of this adverse effect. Herein, we report the case of a 34-years old female patient with diffuse large B-cell lymphoma who developed progressive paraplegia accompanied by dysfunctional bladder and bowel movements after treatment with a modified CODOX-M/IVAC regimen, including high-dose intravenous MTX and intrathecal (IT-) MT...
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Takashi Miyoshi Tadakazu Kondo Momoko Nishikori Toshio Kitawaki Katsuya Kobayashi Masakazu Fujimoto Noriyoshi Yoshinaga Satoshi Oka Kohsuke Asagoe Shinsaku Imashuku Akifumi Takaori-Kondo Source Type: research
Coincidence of de novo T-lymphoblastic lymphoma and cutaneous gamma/delta peripheral T-cell lymphoma
J Clin Exp Hematop. 2023;63(4):257-261. doi: 10.3960/jslrt.23042.ABSTRACTThe coincidence of acute T-lymphoblastic leukemia/lymphoma, NOS (T-ALL/LBL), and peripheral T-cell lymphoma (PTCL) is unusual, and there have only been a few cases of their metachronous occurrence. In these cases, PTCLs emerged as recurrence after primary therapy for primary T-ALL, were the rare gamma/delta type, and uncommonly involved skin for T-ALL/LBL. We herein report the first case of de novo T-LBL that coincided with cutaneous gamma/delta PTCL before primary therapy. A 70-year-old man presented with systemic lymphadenopathy. Lymph node biopsy r...
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Tsugumi Satoh Hidekazu Kayano Mika Kohri Ken Tanae Chie Asou Naoki Takahashi Kunihiro Tsukasaki Masanori Yasuda Source Type: research
Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma
J Clin Exp Hematop. 2023;63(4):262-265. doi: 10.3960/jslrt.23043.NO ABSTRACTPMID:38148017 | DOI:10.3960/jslrt.23043 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Yasunobu Sekiguchi Hiroki Tsutsumi Ayumi Gomyo Masahisa Kudo Yoshie Iizaki Nobuo Maseki Machiko Kawamura Kazuhiko Kobayashi Yu Nishimura Hiroaki Kanda Hideaki Nitta Masaaki Noguchi Hirofumi Kobayashi Source Type: research
Highlights: Follicular lymphoma
J Clin Exp Hematop. 2023;63(4):212-213. doi: 10.3960/jslrt.23051.NO ABSTRACTPMID:38148010 | DOI:10.3960/jslrt.23051 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Katsuyoshi Takata Source Type: research
Clinico-pathological profile of patients with plasma cell neoplasms with special reference to bone marrow fibrosis and amyloid deposition
In conclusion, the incidence of fibrosis (4.3%) and amyloidosis (6.2%) associated with plasma cell neoplasms were much lower in our study as compared to published studies.PMID:38148011 | DOI:10.3960/jslrt.23029 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Narasimhapriyan Kannan Jasmita Dass Sahitya Dangudubiyyam Ganesh Kumar Viswanathan Mukul Aggarwal Pradeep Kumar Rishi Dhawan Tulika Seth Manoranjan Mahapatra Source Type: research
Treatment patterns in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma post covalent Bruton tyrosine kinase inhibitor treatment: a Japanese claims database study
In conclusion, Japanese patients with CLL/SLL received various treatments for short duration after first-cBTKi discontinuation.PMID:38148012 | DOI:10.3960/jslrt.23032 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Dai Maruyama Chaochen Wang Yoshinori Tanizawa Zhihong Cai Yujing Huang Masaomi Tajimi Shigeru Kusumoto Source Type: research
Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma
In this study, we aimed to investigate the prevalence of EBV among HL cases in Ethiopia and to assess the tissue cellular composition of EBV-related and EBV-unrelated cases. We constructed a tissue microarray (TMA) of 126 consecutive cases of classical HL (CHL) and nodular lymphocyte predominant HL (NLPHL) from a tertiary cancer centre, Tikur Anbessa Hospital, Addis Ababa, Ethiopia, and evaluated a panel of immunohistochemical markers. The quantification of immune cells was performed using HALO 2.3, a platform for image analysis from Indica Lab Inc. A total of 77/126 (61.1%) of HL cases expressed LMP1/EBER. Infiltration of...
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Makka Adam Yonas Bekuretsion Amha Gebremedhin Anna Kwiecinska Rawleigh Howe Beyene Petros Mats Jerkeman Source Type: research
Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease
This report suggests that appropriate sutimlimab administration can suppress SARS-CoV-2 mRNA vaccination-induced CAD exacerbation, and that it could be a preventive strategy to minimize hemolytic attacks in susceptible populations.PMID:38148014 | DOI:10.3960/jslrt.23040 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Hiroki Kobayashi Tomoki Ouchi Wataru Kitamura Shoji Asakura Tomofumi Yano Hiromasa Takeda Yoshiyuki Tokuda Tadashi Yoshino Yoshinobu Maeda Source Type: research
Methotrexate-induced subacute myelopathy: a serious but treatable complication
J Clin Exp Hematop. 2023;63(4):251-256. doi: 10.3960/jslrt.23041.ABSTRACTSubacute myelopathy is a rare but serious complication of methotrexate (MTX) that may cause paraplegia. Although its underlying mechanisms have not been fully elucidated, homocysteine is thought to play a role in the pathogenesis of this adverse effect. Herein, we report the case of a 34-years old female patient with diffuse large B-cell lymphoma who developed progressive paraplegia accompanied by dysfunctional bladder and bowel movements after treatment with a modified CODOX-M/IVAC regimen, including high-dose intravenous MTX and intrathecal (IT-) MT...
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Takashi Miyoshi Tadakazu Kondo Momoko Nishikori Toshio Kitawaki Katsuya Kobayashi Masakazu Fujimoto Noriyoshi Yoshinaga Satoshi Oka Kohsuke Asagoe Shinsaku Imashuku Akifumi Takaori-Kondo Source Type: research
Coincidence of de novo T-lymphoblastic lymphoma and cutaneous gamma/delta peripheral T-cell lymphoma
J Clin Exp Hematop. 2023;63(4):257-261. doi: 10.3960/jslrt.23042.ABSTRACTThe coincidence of acute T-lymphoblastic leukemia/lymphoma, NOS (T-ALL/LBL), and peripheral T-cell lymphoma (PTCL) is unusual, and there have only been a few cases of their metachronous occurrence. In these cases, PTCLs emerged as recurrence after primary therapy for primary T-ALL, were the rare gamma/delta type, and uncommonly involved skin for T-ALL/LBL. We herein report the first case of de novo T-LBL that coincided with cutaneous gamma/delta PTCL before primary therapy. A 70-year-old man presented with systemic lymphadenopathy. Lymph node biopsy r...
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Tsugumi Satoh Hidekazu Kayano Mika Kohri Ken Tanae Chie Asou Naoki Takahashi Kunihiro Tsukasaki Masanori Yasuda Source Type: research
Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma
J Clin Exp Hematop. 2023;63(4):262-265. doi: 10.3960/jslrt.23043.NO ABSTRACTPMID:38148017 | DOI:10.3960/jslrt.23043 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Yasunobu Sekiguchi Hiroki Tsutsumi Ayumi Gomyo Masahisa Kudo Yoshie Iizaki Nobuo Maseki Machiko Kawamura Kazuhiko Kobayashi Yu Nishimura Hiroaki Kanda Hideaki Nitta Masaaki Noguchi Hirofumi Kobayashi Source Type: research
Significant response of patients with transformed follicular lymphoma with rapid disease progression to CAR-T therapy
J Clin Exp Hematop. 2023 Dec 26;63(4):266-269. doi: 10.3960/jslrt.23033. Epub 2023 Nov 30.NO ABSTRACTPMID:38030235 | DOI:10.3960/jslrt.23033 (Source: Journal of Clinical and Experimental Hematopathology : JCEH)
Source: Journal of Clinical and Experimental Hematopathology : JCEH - November 29, 2023 Category: Hematology Authors: Taichi Hirano Hiro Tatetsu Shikiko Ueno Takafumi Shichijo Shota Furukawa Mizuho Tsujihashi Toshikazu Miyakawa Shinya Shiraishi Yusuke Higuchi Mitsuhiro Uchiba Jun-Ichirou Yasunaga Kisato Nosaka Masao Matsuoka Source Type: research